An Official Website of the United States Government
Company Information:
Name:
OSTEOGENEX, INC
Address:
OSTEOGENEX, INC
PO Box 3132
Kansas city, KS 66103
PO Box 3132
Kansas city, KS 66103
Located in HUBZone:
No
Woman-Owned:
Yes
Minority-Owned:
No
URL:
N/A
Phone:
N/A
Award Totals:
Award List:
Therapeutics for increasing Bone Density and Quality
Award Year / Program / Phase:
2006 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Debra L. Ellies
Award Amount:
$133,904.00
Abstract:
DESCRIPTION (provided by applicant): Osteoporosis affects 55% of Americans over the age of 50, and incurs a medical cost of $47 million a day. It is caused by a disruption in the fine equilibrium between bone resorption and bone deposition. Currently, the most successful pharmaceutical drugs for… More
Anabolic Therapeutics for Increasing Bone Denisty and Quality
Award Year / Program / Phase:
2008 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Award Amount:
$994,943.00
Abstract:
DESCRIPTION (provided by applicant): OsteoGeneX is developing a therapeutic directed against the new bone target Sclerostin (SOST) for the treatment of osteoporosis and related bone disorders. Through genomic approaches Sclerostin was identified as a mast
er regulator of bone mass affecting men and… More